The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...

Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight According to DelveInsight’s analysis, the market for ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years.

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations ... and Drug Administration to treat gastrointestinal stromal tumors ... Mar. 10, 2025 — In a study ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

Crown BioScience experts explore how 3D in vitro assays mimic the suppressive tumor microenvironment to improve drug response ...